Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer (NSCLC) and kidney cancer. The ...
Sep 26, 2019
0
1
Scientists at the University of Birmingham have found an anti-malarial drug was effective in treating head and neck cancer in mice.
Sep 25, 2019
0
92
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, ...
Sep 18, 2019
0
4
Researchers at the University of North Carolina Chapel Hill and RTI International (RTI), a nonprofit research institute, recently found that patients with early rheumatoid arthritis (RA) may see less disease activity and ...
Aug 22, 2019
0
3
A study from Vanderbilt-Ingram Cancer Center and the Department of Veterans Affairs led by Anna Vilgelm, MD, Ph.D., and Ann Richmond, Ph.D., has identified a possible second-line treatment for melanoma patients.
Aug 15, 2019
0
32
Are you enjoying the summer? Out grilling, swimming and hiking? Beware: those sunny days may come with a cost.
Jul 31, 2019
0
1
A combination of enzalutamide and androgen deprivation therapy (ADT) significantly reduced the risk of metastatic progression or death over time in men with advanced prostate cancer, according to the results of clinical trial ...
Jul 30, 2019
0
12
Massive hemorrhage, or excessive bleeding, is a potentially preventable yet a major cause of death in trauma patients.
Jul 30, 2019
0
0
Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports.
Jul 23, 2019
0
3
The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase ...
Jul 6, 2019
0
2
